To date, the only oral GLP-1 receptor agonist available for clinical use is oral semaglutide
Although the significance of this finding requires further investigation, it suggests that GLP-1 RA therapy could help facilitate more adaptive behaviors, especially in individuals struggling with compulsive eating or substance use, by potentially enhancing their capacity for new learning and behavioral flexibility
A single drug class reducing risk across every major addictive substance, by acting on a shared craving mechanism rather than targeting individual substances, points toward a fundamentally different framework for understanding addiction
~711.9 g/mol) supports clean resolution by size-exclusion chromatography and unambiguous discrimination in LC-MS workflows, and reference laboratories routinely use such disparate mass pairs to challenge dynamic range, ion suppression, and peak-capacity parameters
APOE-amyloid interaction: therapeutic targets
This information will help your GP assess whether there is a temporal relationship with Ozempic initiation or dose changes
